TAZICEF - ADD-VANTAGE Principal Display Panel (ceftazidime for injection, USP - ADD-VANTAGE)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

NDC 0409-5092-11
equivalent to
1 gram ceftazidime

TAZICEF®
CEFTAZIDIME
FOR INJECTION, USP

For Intravenous Infusion Only

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

25 ADD-Vantage® Vials

NDC 0409-5092-16

TAZICEF®
CEFTAZIDIME FOR INJECTION, USP

equivalent to 1 gram ceftazidime

Rx only

For Intravenous Infusion Only

Note: For use only with ADD-Vantage® diluent container.

Store at 20° to 25°C (68° to 77°F)
[See USP Controlled Room Temperature].

Hospira

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

NDC 0409-5093-14

equivalent to
2 grams ceftazidime

TAZICEF®
CEFTAZIDIME
FOR INJECTION, USP

For Intravenous Infusion Only

Rx only

Hospira

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

NDC 0409-5093-11

TAZICEF®
CEFTAZIDIME FOR INJECTION, USP

Rx only

equivalent to 2 grams ceftazidime

For Intravenous Infusion Only

10 ADD-Vantage® Vials

Hospira

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TAZICEF - ADD-VANTAGE Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.

If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

Tazicef (ceftazidime for injection, USP) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases:

1....